Further benefits by early start of HIV treatment in low income countries: Survival estimates of early versus deferred antiretroviral therapy

BACKGROUND: International HIV guidelines have recently shifted from a medium-late to an early-start treatment strategy. As a consequence, more people will be eligible to Highly Active Antiretroviral Therapy (HAART). We estimate mean life years gained using different treatment indications in low inco...

Full description

Saved in:

Bibliographic Details
Main Authors:	Johansson, Kjell Arne, Robberstad, Bjarne, Norheim, Ole Frithjof
Format:	Artigo
Language:	Inglês
Published:	BioMed Central 2010
Subjects:	Research
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC2836271/ https://ncbi.nlm.nih.gov/pubmed/20180966 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-6405-7-3
Tags:	Add Tag No Tags, Be the first to tag this record!

Further benefits by early start of HIV treatment in low income countries: Survival estimates of early versus deferred antiretroviral therapy

Similar Items